Showing the value of regulatory intelligence in pharma

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/c2/4b/46/c24b4666-10b4-d833-a4ad-77be49cd1422/mza_18369175361314418871.jpeg/600x600bb.jpg

Conversations in Healthcare

Clarivate

48 episodes

9 months ago

Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more.

Hosted on Acast. See acast.com/privacy for more information.

Business News

News

RSS

All content for Conversations in Healthcare is the property of Clarivate and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

Business News

News

https://assets.pippa.io/shows/60b1306d44938a0013db19cf/1623315228296-0f6d70af5a62181f19e3343e22b64ea2.jpeg

Showing the value of regulatory intelligence in pharma

Conversations in Healthcare

31 minutes 32 seconds

4 years ago

Showing the value of regulatory intelligence in pharma

In this episode of Conversations in Healthcare, Mike Ward speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca, and Céline Rodier, Senior Health Policy Manager at Clarivate, about strategies and tools to gather and assess regulatory intelligence, as well as KPIs and approaches to demonstrating ROI within your organization. Get actionable takeaways in the full episode.

Hosted on Acast. See acast.com/privacy for more information.